TH006-01

N/A

Report date: 2025/02/20 16:25:14

Base Information

Drug NameTH006-01
Drug Alias NameTH006-01TH-006-01
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionEphrin type-A receptor 2 antagonists
TargetsEphrin type-A receptor 2
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Bangentai Biomedical Tech Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Bangentai Biomedical Tech Group Co Ltd
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A